nodes	percent_of_prediction	percent_of_DWPC	metapath
Carvedilol—ABCB1—Methylprednisolone—psoriatic arthritis	0.0601	0.118	CbGbCtD
Carvedilol—CYP1A1—Dexamethasone—psoriatic arthritis	0.0582	0.114	CbGbCtD
Carvedilol—CYP2E1—Dexamethasone—psoriatic arthritis	0.045	0.0884	CbGbCtD
Carvedilol—ABCB1—Betamethasone—psoriatic arthritis	0.0391	0.0769	CbGbCtD
Carvedilol—ABCB1—Prednisolone—psoriatic arthritis	0.0386	0.0758	CbGbCtD
Carvedilol—ABCB1—Prednisone—psoriatic arthritis	0.0364	0.0716	CbGbCtD
Carvedilol—CYP3A4—Methylprednisolone—psoriatic arthritis	0.036	0.0708	CbGbCtD
Carvedilol—CYP3A4—Triamcinolone—psoriatic arthritis	0.0273	0.0537	CbGbCtD
Carvedilol—CYP2C9—Dexamethasone—psoriatic arthritis	0.0234	0.0461	CbGbCtD
Carvedilol—CYP3A4—Betamethasone—psoriatic arthritis	0.0234	0.046	CbGbCtD
Carvedilol—CYP3A4—Prednisolone—psoriatic arthritis	0.0231	0.0454	CbGbCtD
Carvedilol—ABCB1—Dexamethasone—psoriatic arthritis	0.0227	0.0447	CbGbCtD
Carvedilol—CYP3A4—Prednisone—psoriatic arthritis	0.0218	0.0429	CbGbCtD
Carvedilol—CYP2D6—Dexamethasone—psoriatic arthritis	0.0214	0.0421	CbGbCtD
Carvedilol—ABCB1—Methotrexate—psoriatic arthritis	0.0183	0.0359	CbGbCtD
Carvedilol—VCAM1—synovial membrane of synovial joint—psoriatic arthritis	0.0171	0.378	CbGeAlD
Carvedilol—CYP3A4—Dexamethasone—psoriatic arthritis	0.0136	0.0268	CbGbCtD
Carvedilol—SELE—ATF-2 transcription factor network—IL23A—psoriatic arthritis	0.0126	0.127	CbGpPWpGaD
Carvedilol—SELE—Glucocorticoid receptor regulatory network—IL13—psoriatic arthritis	0.00493	0.0497	CbGpPWpGaD
Carvedilol—SELE—TNF alpha Signaling Pathway—REL—psoriatic arthritis	0.00491	0.0495	CbGpPWpGaD
Carvedilol—SELE—TNF alpha Signaling Pathway—TNFRSF1B—psoriatic arthritis	0.00464	0.0468	CbGpPWpGaD
Carvedilol—XDH—Effects of Nitric Oxide—NOS2—psoriatic arthritis	0.0045	0.0454	CbGpPWpGaD
Carvedilol—VCAM1—Alpha9 beta1 integrin signaling events—NOS2—psoriatic arthritis	0.00403	0.0406	CbGpPWpGaD
Carvedilol—VCAM1—Interferon gamma signaling—HLA-C—psoriatic arthritis	0.00375	0.0378	CbGpPWpGaD
Carvedilol—VCAM1—Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell—HLA-C—psoriatic arthritis	0.00371	0.0374	CbGpPWpGaD
Carvedilol—SELE—skin of body—psoriatic arthritis	0.00369	0.0816	CbGeAlD
Carvedilol—HIF1A—skin of body—psoriatic arthritis	0.00327	0.0723	CbGeAlD
Carvedilol—GJA1—skin of body—psoriatic arthritis	0.00317	0.0701	CbGeAlD
Carvedilol—SELE—ATF-2 transcription factor network—NOS2—psoriatic arthritis	0.00308	0.031	CbGpPWpGaD
Carvedilol—SELE—tendon—psoriatic arthritis	0.00281	0.0622	CbGeAlD
Carvedilol—VCAM1—tendon—psoriatic arthritis	0.00258	0.0572	CbGeAlD
Carvedilol—HIF1A—tendon—psoriatic arthritis	0.00249	0.055	CbGeAlD
Carvedilol—GJA1—tendon—psoriatic arthritis	0.00241	0.0534	CbGeAlD
Carvedilol—NPPB—MicroRNAs in cardiomyocyte hypertrophy—TNF—psoriatic arthritis	0.00236	0.0237	CbGpPWpGaD
Carvedilol—VCAM1—Interferon gamma signaling—HLA-B—psoriatic arthritis	0.00222	0.0224	CbGpPWpGaD
Carvedilol—VCAM1—Cellular roles of Anthrax toxin—TNF—psoriatic arthritis	0.00222	0.0223	CbGpPWpGaD
Carvedilol—VCAM1—Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell—HLA-B—psoriatic arthritis	0.00219	0.0221	CbGpPWpGaD
Carvedilol—NDUFC2—tendon—psoriatic arthritis	0.0021	0.0464	CbGeAlD
Carvedilol—VEGFA—tendon—psoriatic arthritis	0.0019	0.0421	CbGeAlD
Carvedilol—VCAM1—Interferon gamma signaling—HLA-DRB1—psoriatic arthritis	0.00188	0.0189	CbGpPWpGaD
Carvedilol—VCAM1—Interferon Signaling—HLA-C—psoriatic arthritis	0.00183	0.0185	CbGpPWpGaD
Carvedilol—GJA1—SIDS Susceptibility Pathways—IL13—psoriatic arthritis	0.00178	0.018	CbGpPWpGaD
Carvedilol—HIF1A—SIDS Susceptibility Pathways—IL13—psoriatic arthritis	0.00172	0.0173	CbGpPWpGaD
Carvedilol—HIF1A—HIF-1-alpha transcription factor network—NOS2—psoriatic arthritis	0.00164	0.0166	CbGpPWpGaD
Carvedilol—HIF1A—AGE/RAGE pathway—NOS2—psoriatic arthritis	0.00164	0.0166	CbGpPWpGaD
Carvedilol—GJA1—Cortisone acetate—Methylprednisolone—psoriatic arthritis	0.00157	0.102	CbGdCrCtD
Carvedilol—VEGFA—Alpha9 beta1 integrin signaling events—NOS2—psoriatic arthritis	0.00154	0.0155	CbGpPWpGaD
Carvedilol—GJA1—Cortisone acetate—Prednisone—psoriatic arthritis	0.00143	0.0929	CbGdCrCtD
Carvedilol—GJA1—Cortisone acetate—Prednisolone—psoriatic arthritis	0.0014	0.0907	CbGdCrCtD
Carvedilol—VEGFA—Allograft Rejection—HLA-C—psoriatic arthritis	0.00129	0.013	CbGpPWpGaD
Carvedilol—VEGFA—Allograft Rejection—IL13—psoriatic arthritis	0.00128	0.0129	CbGpPWpGaD
Carvedilol—VCAM1—Cytokine Signaling in Immune system—HLA-C—psoriatic arthritis	0.00122	0.0123	CbGpPWpGaD
Carvedilol—VEGFA—Allograft Rejection—IL17A—psoriatic arthritis	0.00118	0.0119	CbGpPWpGaD
Carvedilol—PTGS1—Overview of nanoparticle effects—CRP—psoriatic arthritis	0.00116	0.0117	CbGpPWpGaD
Carvedilol—VEGFA—Allograft Rejection—IL12B—psoriatic arthritis	0.00109	0.011	CbGpPWpGaD
Carvedilol—VCAM1—Interferon Signaling—HLA-B—psoriatic arthritis	0.00108	0.0109	CbGpPWpGaD
Carvedilol—GJA1—Spinal Cord Injury—NOS2—psoriatic arthritis	0.00107	0.0108	CbGpPWpGaD
Carvedilol—SELE—TNF alpha Signaling Pathway—TNF—psoriatic arthritis	0.00107	0.0108	CbGpPWpGaD
Carvedilol—GJA1—Rimexolone—Methylprednisolone—psoriatic arthritis	0.00106	0.0685	CbGdCrCtD
Carvedilol—GJA1—Rimexolone—Dexamethasone—psoriatic arthritis	0.00104	0.0674	CbGdCrCtD
Carvedilol—GJA1—Rimexolone—Betamethasone—psoriatic arthritis	0.00104	0.0674	CbGdCrCtD
Carvedilol—GJA1—Rimexolone—Triamcinolone—psoriatic arthritis	0.00102	0.0659	CbGdCrCtD
Carvedilol—GJA1—Rimexolone—Prednisone—psoriatic arthritis	0.000965	0.0625	CbGdCrCtD
Carvedilol—GJA1—Rimexolone—Prednisolone—psoriatic arthritis	0.000942	0.061	CbGdCrCtD
Carvedilol—VCAM1—Interferon Signaling—HLA-DRB1—psoriatic arthritis	0.000917	0.00925	CbGpPWpGaD
Carvedilol—VCAM1—Cytokine Signaling in Immune system—NOD2—psoriatic arthritis	0.0009	0.00907	CbGpPWpGaD
Carvedilol—VCAM1—Immune System—MEFV—psoriatic arthritis	0.000781	0.00787	CbGpPWpGaD
Carvedilol—CYP1A1—skin of body—psoriatic arthritis	0.000766	0.0169	CbGeAlD
Carvedilol—VEGFA—Allograft Rejection—HLA-B—psoriatic arthritis	0.000762	0.00767	CbGpPWpGaD
Carvedilol—VEGFA—SIDS Susceptibility Pathways—IL13—psoriatic arthritis	0.000743	0.00748	CbGpPWpGaD
Carvedilol—XDH—Selenium Micronutrient Network—CRP—psoriatic arthritis	0.000725	0.0073	CbGpPWpGaD
Carvedilol—VCAM1—Cytokine Signaling in Immune system—HLA-B—psoriatic arthritis	0.000724	0.00729	CbGpPWpGaD
Carvedilol—VCAM1—Adaptive Immune System—REL—psoriatic arthritis	0.000716	0.00722	CbGpPWpGaD
Carvedilol—VEGFA—HIF-1-alpha transcription factor network—NOS2—psoriatic arthritis	0.000709	0.00714	CbGpPWpGaD
Carvedilol—GJA1—Progesterone—Prednisolone—psoriatic arthritis	0.000685	0.0444	CbGdCrCtD
Carvedilol—ADRA2C—tendon—psoriatic arthritis	0.000681	0.0151	CbGeAlD
Carvedilol—KCNH2—SIDS Susceptibility Pathways—IL13—psoriatic arthritis	0.000673	0.00679	CbGpPWpGaD
Carvedilol—PTGS1—skin of body—psoriatic arthritis	0.000673	0.0149	CbGeAlD
Carvedilol—VCAM1—Adaptive Immune System—HLA-C—psoriatic arthritis	0.000659	0.00664	CbGpPWpGaD
Carvedilol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriatic arthritis	0.000653	0.00659	CbGpPWpGaD
Carvedilol—VEGFA—Allograft Rejection—HLA-DRB1—psoriatic arthritis	0.000645	0.0065	CbGpPWpGaD
Carvedilol—VCAM1—Cytokine Signaling in Immune system—HLA-DRB1—psoriatic arthritis	0.000613	0.00617	CbGpPWpGaD
Carvedilol—SELE—Hemostasis—NOS2—psoriatic arthritis	0.000551	0.00555	CbGpPWpGaD
Carvedilol—ADRA2A—tendon—psoriatic arthritis	0.000543	0.012	CbGeAlD
Carvedilol—CYP2E1—tendon—psoriatic arthritis	0.000532	0.0118	CbGeAlD
Carvedilol—GJA1—Spinal Cord Injury—TNF—psoriatic arthritis	0.000531	0.00535	CbGpPWpGaD
Carvedilol—PTGS1—Overview of nanoparticle effects—TNF—psoriatic arthritis	0.000524	0.00528	CbGpPWpGaD
Carvedilol—PTGS1—tendon—psoriatic arthritis	0.000512	0.0113	CbGeAlD
Carvedilol—HIF1A—Adipogenesis—TNF—psoriatic arthritis	0.000474	0.00478	CbGpPWpGaD
Carvedilol—VEGFA—Aryl Hydrocarbon Receptor—TNF—psoriatic arthritis	0.00047	0.00473	CbGpPWpGaD
Carvedilol—VCAM1—Immune System—REL—psoriatic arthritis	0.000434	0.00438	CbGpPWpGaD
Carvedilol—GJA1—SIDS Susceptibility Pathways—TNF—psoriatic arthritis	0.000425	0.00428	CbGpPWpGaD
Carvedilol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriatic arthritis	0.000417	0.0042	CbGpPWpGaD
Carvedilol—HIF1A—SIDS Susceptibility Pathways—TNF—psoriatic arthritis	0.00041	0.00413	CbGpPWpGaD
Carvedilol—Angiopathy—Prednisone—psoriatic arthritis	0.000409	0.00123	CcSEcCtD
Carvedilol—Confusional state—Methylprednisolone—psoriatic arthritis	0.000408	0.00123	CcSEcCtD
Carvedilol—Immune system disorder—Prednisone—psoriatic arthritis	0.000407	0.00123	CcSEcCtD
Carvedilol—Malaise—Betamethasone—psoriatic arthritis	0.000406	0.00123	CcSEcCtD
Carvedilol—Malaise—Dexamethasone—psoriatic arthritis	0.000406	0.00123	CcSEcCtD
Carvedilol—Oedema—Triamcinolone—psoriatic arthritis	0.000405	0.00122	CcSEcCtD
Carvedilol—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.000405	0.00122	CcSEcCtD
Carvedilol—Vertigo—Dexamethasone—psoriatic arthritis	0.000405	0.00122	CcSEcCtD
Carvedilol—Vertigo—Betamethasone—psoriatic arthritis	0.000405	0.00122	CcSEcCtD
Carvedilol—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.000404	0.00122	CcSEcCtD
Carvedilol—Syncope—Betamethasone—psoriatic arthritis	0.000404	0.00122	CcSEcCtD
Carvedilol—Syncope—Dexamethasone—psoriatic arthritis	0.000404	0.00122	CcSEcCtD
Carvedilol—Infection—Triamcinolone—psoriatic arthritis	0.000403	0.00121	CcSEcCtD
Carvedilol—Infection—Methylprednisolone—psoriatic arthritis	0.000402	0.00121	CcSEcCtD
Carvedilol—Haematuria—Methotrexate—psoriatic arthritis	0.0004	0.00121	CcSEcCtD
Carvedilol—VCAM1—Immune System—HLA-C—psoriatic arthritis	0.0004	0.00403	CbGpPWpGaD
Carvedilol—Shock—Triamcinolone—psoriatic arthritis	0.000399	0.0012	CcSEcCtD
Carvedilol—Insomnia—Prednisolone—psoriatic arthritis	0.000399	0.0012	CcSEcCtD
Carvedilol—Alopecia—Prednisone—psoriatic arthritis	0.000398	0.0012	CcSEcCtD
Carvedilol—ABCB1—Allograft Rejection—HLA-C—psoriatic arthritis	0.000398	0.00401	CbGpPWpGaD
Carvedilol—Shock—Methylprednisolone—psoriatic arthritis	0.000398	0.0012	CcSEcCtD
Carvedilol—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000396	0.00119	CcSEcCtD
Carvedilol—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000396	0.00119	CcSEcCtD
Carvedilol—ABCB1—Allograft Rejection—IL13—psoriatic arthritis	0.000396	0.00399	CbGpPWpGaD
Carvedilol—Paraesthesia—Prednisolone—psoriatic arthritis	0.000396	0.00119	CcSEcCtD
Carvedilol—Tachycardia—Triamcinolone—psoriatic arthritis	0.000396	0.00119	CcSEcCtD
Carvedilol—Tachycardia—Methylprednisolone—psoriatic arthritis	0.000395	0.00119	CcSEcCtD
Carvedilol—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000393	0.00118	CcSEcCtD
Carvedilol—Malnutrition—Prednisone—psoriatic arthritis	0.000392	0.00118	CcSEcCtD
Carvedilol—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.000392	0.00118	CcSEcCtD
Carvedilol—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.000391	0.00118	CcSEcCtD
Carvedilol—Convulsion—Betamethasone—psoriatic arthritis	0.00039	0.00118	CcSEcCtD
Carvedilol—Convulsion—Dexamethasone—psoriatic arthritis	0.00039	0.00118	CcSEcCtD
Carvedilol—VCAM1—Adaptive Immune System—HLA-B—psoriatic arthritis	0.00039	0.00393	CbGpPWpGaD
Carvedilol—Hypertension—Dexamethasone—psoriatic arthritis	0.000389	0.00117	CcSEcCtD
Carvedilol—Hypertension—Betamethasone—psoriatic arthritis	0.000389	0.00117	CcSEcCtD
Carvedilol—Myalgia—Betamethasone—psoriatic arthritis	0.000384	0.00116	CcSEcCtD
Carvedilol—Myalgia—Dexamethasone—psoriatic arthritis	0.000384	0.00116	CcSEcCtD
Carvedilol—Discomfort—Dexamethasone—psoriatic arthritis	0.000379	0.00114	CcSEcCtD
Carvedilol—Discomfort—Betamethasone—psoriatic arthritis	0.000379	0.00114	CcSEcCtD
Carvedilol—Haemoglobin—Methotrexate—psoriatic arthritis	0.000379	0.00114	CcSEcCtD
Carvedilol—Hypotension—Methylprednisolone—psoriatic arthritis	0.000378	0.00114	CcSEcCtD
Carvedilol—Pain—Prednisolone—psoriatic arthritis	0.000377	0.00114	CcSEcCtD
Carvedilol—Haemorrhage—Methotrexate—psoriatic arthritis	0.000377	0.00114	CcSEcCtD
Carvedilol—Pharyngitis—Methotrexate—psoriatic arthritis	0.000374	0.00113	CcSEcCtD
Carvedilol—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.000372	0.00112	CcSEcCtD
Carvedilol—Vision blurred—Prednisone—psoriatic arthritis	0.00037	0.00112	CcSEcCtD
Carvedilol—Urethral disorder—Methotrexate—psoriatic arthritis	0.000369	0.00111	CcSEcCtD
Carvedilol—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000369	0.00111	CcSEcCtD
Carvedilol—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000368	0.00111	CcSEcCtD
Carvedilol—Oedema—Betamethasone—psoriatic arthritis	0.000368	0.00111	CcSEcCtD
Carvedilol—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.000368	0.00111	CcSEcCtD
Carvedilol—Oedema—Dexamethasone—psoriatic arthritis	0.000368	0.00111	CcSEcCtD
Carvedilol—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.000368	0.00111	CcSEcCtD
Carvedilol—Insomnia—Triamcinolone—psoriatic arthritis	0.000367	0.00111	CcSEcCtD
Carvedilol—Insomnia—Methylprednisolone—psoriatic arthritis	0.000366	0.0011	CcSEcCtD
Carvedilol—Infection—Betamethasone—psoriatic arthritis	0.000365	0.0011	CcSEcCtD
Carvedilol—Infection—Dexamethasone—psoriatic arthritis	0.000365	0.0011	CcSEcCtD
Carvedilol—ABCB1—Allograft Rejection—IL17A—psoriatic arthritis	0.000364	0.00367	CbGpPWpGaD
Carvedilol—Ill-defined disorder—Prednisone—psoriatic arthritis	0.000364	0.0011	CcSEcCtD
Carvedilol—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000364	0.0011	CcSEcCtD
Carvedilol—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000363	0.0011	CcSEcCtD
Carvedilol—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000363	0.0011	CcSEcCtD
Carvedilol—Visual impairment—Methotrexate—psoriatic arthritis	0.000363	0.0011	CcSEcCtD
Carvedilol—Anaemia—Prednisone—psoriatic arthritis	0.000363	0.00109	CcSEcCtD
Carvedilol—Shock—Dexamethasone—psoriatic arthritis	0.000362	0.00109	CcSEcCtD
Carvedilol—Shock—Betamethasone—psoriatic arthritis	0.000362	0.00109	CcSEcCtD
Carvedilol—Dyspnoea—Triamcinolone—psoriatic arthritis	0.000361	0.00109	CcSEcCtD
Carvedilol—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.00036	0.00109	CcSEcCtD
Carvedilol—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.00036	0.00109	CcSEcCtD
Carvedilol—Tachycardia—Betamethasone—psoriatic arthritis	0.000359	0.00108	CcSEcCtD
Carvedilol—Tachycardia—Dexamethasone—psoriatic arthritis	0.000359	0.00108	CcSEcCtD
Carvedilol—Angioedema—Prednisone—psoriatic arthritis	0.000359	0.00108	CcSEcCtD
Carvedilol—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000357	0.00108	CcSEcCtD
Carvedilol—Erythema multiforme—Methotrexate—psoriatic arthritis	0.000356	0.00107	CcSEcCtD
Carvedilol—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000356	0.00107	CcSEcCtD
Carvedilol—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000355	0.00107	CcSEcCtD
Carvedilol—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000355	0.00107	CcSEcCtD
Carvedilol—Malaise—Prednisone—psoriatic arthritis	0.000354	0.00107	CcSEcCtD
Carvedilol—Vertigo—Prednisone—psoriatic arthritis	0.000353	0.00106	CcSEcCtD
Carvedilol—Syncope—Prednisone—psoriatic arthritis	0.000352	0.00106	CcSEcCtD
Carvedilol—Tinnitus—Methotrexate—psoriatic arthritis	0.000351	0.00106	CcSEcCtD
Carvedilol—Anorexia—Dexamethasone—psoriatic arthritis	0.000351	0.00106	CcSEcCtD
Carvedilol—Anorexia—Betamethasone—psoriatic arthritis	0.000351	0.00106	CcSEcCtD
Carvedilol—Urticaria—Prednisolone—psoriatic arthritis	0.00035	0.00106	CcSEcCtD
Carvedilol—Fatigue—Triamcinolone—psoriatic arthritis	0.000349	0.00105	CcSEcCtD
Carvedilol—Fatigue—Methylprednisolone—psoriatic arthritis	0.000349	0.00105	CcSEcCtD
Carvedilol—Pain—Triamcinolone—psoriatic arthritis	0.000347	0.00105	CcSEcCtD
Carvedilol—Loss of consciousness—Prednisone—psoriatic arthritis	0.000345	0.00104	CcSEcCtD
Carvedilol—Hypotension—Betamethasone—psoriatic arthritis	0.000344	0.00104	CcSEcCtD
Carvedilol—Hypotension—Dexamethasone—psoriatic arthritis	0.000344	0.00104	CcSEcCtD
Carvedilol—Angiopathy—Methotrexate—psoriatic arthritis	0.000342	0.00103	CcSEcCtD
Carvedilol—Immune system disorder—Methotrexate—psoriatic arthritis	0.00034	0.00103	CcSEcCtD
Carvedilol—Convulsion—Prednisone—psoriatic arthritis	0.00034	0.00103	CcSEcCtD
Carvedilol—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000339	0.00102	CcSEcCtD
Carvedilol—PTGS1—Selenium Micronutrient Network—CRP—psoriatic arthritis	0.000339	0.00342	CbGpPWpGaD
Carvedilol—Hypertension—Prednisone—psoriatic arthritis	0.000339	0.00102	CcSEcCtD
Carvedilol—ABCB1—Allograft Rejection—IL12B—psoriatic arthritis	0.000339	0.00341	CbGpPWpGaD
Carvedilol—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000335	0.00101	CcSEcCtD
Carvedilol—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000335	0.00101	CcSEcCtD
Carvedilol—Arthralgia—Prednisone—psoriatic arthritis	0.000334	0.00101	CcSEcCtD
Carvedilol—Myalgia—Prednisone—psoriatic arthritis	0.000334	0.00101	CcSEcCtD
Carvedilol—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000334	0.00101	CcSEcCtD
Carvedilol—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000333	0.00101	CcSEcCtD
Carvedilol—Alopecia—Methotrexate—psoriatic arthritis	0.000333	0.001	CcSEcCtD
Carvedilol—Insomnia—Betamethasone—psoriatic arthritis	0.000333	0.001	CcSEcCtD
Carvedilol—Insomnia—Dexamethasone—psoriatic arthritis	0.000333	0.001	CcSEcCtD
Carvedilol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000332	0.001	CcSEcCtD
Carvedilol—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000331	0.000997	CcSEcCtD
Carvedilol—Paraesthesia—Dexamethasone—psoriatic arthritis	0.00033	0.000996	CcSEcCtD
Carvedilol—Paraesthesia—Betamethasone—psoriatic arthritis	0.00033	0.000996	CcSEcCtD
Carvedilol—Discomfort—Prednisone—psoriatic arthritis	0.00033	0.000996	CcSEcCtD
Carvedilol—VCAM1—Adaptive Immune System—HLA-DRB1—psoriatic arthritis	0.00033	0.00332	CbGpPWpGaD
Carvedilol—XDH—Selenium Micronutrient Network—TNF—psoriatic arthritis	0.000328	0.00331	CbGpPWpGaD
Carvedilol—Malnutrition—Methotrexate—psoriatic arthritis	0.000328	0.000989	CcSEcCtD
Carvedilol—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000325	0.000979	CcSEcCtD
Carvedilol—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000324	0.000976	CcSEcCtD
Carvedilol—Dyspepsia—Betamethasone—psoriatic arthritis	0.000324	0.000976	CcSEcCtD
Carvedilol—Urticaria—Triamcinolone—psoriatic arthritis	0.000322	0.000971	CcSEcCtD
Carvedilol—Urticaria—Methylprednisolone—psoriatic arthritis	0.000321	0.000969	CcSEcCtD
Carvedilol—Body temperature increased—Triamcinolone—psoriatic arthritis	0.00032	0.000966	CcSEcCtD
Carvedilol—Oedema—Prednisone—psoriatic arthritis	0.00032	0.000966	CcSEcCtD
Carvedilol—Anaphylactic shock—Prednisone—psoriatic arthritis	0.00032	0.000966	CcSEcCtD
Carvedilol—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.00032	0.000964	CcSEcCtD
Carvedilol—Decreased appetite—Dexamethasone—psoriatic arthritis	0.00032	0.000964	CcSEcCtD
Carvedilol—Decreased appetite—Betamethasone—psoriatic arthritis	0.00032	0.000964	CcSEcCtD
Carvedilol—Infection—Prednisone—psoriatic arthritis	0.000318	0.00096	CcSEcCtD
Carvedilol—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000317	0.000958	CcSEcCtD
Carvedilol—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000317	0.000958	CcSEcCtD
Carvedilol—Back pain—Methotrexate—psoriatic arthritis	0.000317	0.000957	CcSEcCtD
Carvedilol—Fatigue—Dexamethasone—psoriatic arthritis	0.000317	0.000956	CcSEcCtD
Carvedilol—Fatigue—Betamethasone—psoriatic arthritis	0.000317	0.000956	CcSEcCtD
Carvedilol—Shock—Prednisone—psoriatic arthritis	0.000315	0.00095	CcSEcCtD
Carvedilol—Pain—Betamethasone—psoriatic arthritis	0.000314	0.000949	CcSEcCtD
Carvedilol—Pain—Dexamethasone—psoriatic arthritis	0.000314	0.000949	CcSEcCtD
Carvedilol—Tachycardia—Prednisone—psoriatic arthritis	0.000313	0.000943	CcSEcCtD
Carvedilol—Skin disorder—Prednisone—psoriatic arthritis	0.000311	0.000938	CcSEcCtD
Carvedilol—Hyperhidrosis—Prednisone—psoriatic arthritis	0.00031	0.000934	CcSEcCtD
Carvedilol—Vision blurred—Methotrexate—psoriatic arthritis	0.000309	0.000932	CcSEcCtD
Carvedilol—Anorexia—Prednisone—psoriatic arthritis	0.000305	0.000921	CcSEcCtD
Carvedilol—VEGFA—Allograft Rejection—TNF—psoriatic arthritis	0.000305	0.00307	CbGpPWpGaD
Carvedilol—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000304	0.000918	CcSEcCtD
Carvedilol—Anaemia—Methotrexate—psoriatic arthritis	0.000303	0.000914	CcSEcCtD
Carvedilol—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000303	0.000914	CcSEcCtD
Carvedilol—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000303	0.000914	CcSEcCtD
Carvedilol—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000301	0.000907	CcSEcCtD
Carvedilol—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000301	0.000907	CcSEcCtD
Carvedilol—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000299	0.000901	CcSEcCtD
Carvedilol—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000298	0.000899	CcSEcCtD
Carvedilol—Malaise—Methotrexate—psoriatic arthritis	0.000296	0.000892	CcSEcCtD
Carvedilol—Vertigo—Methotrexate—psoriatic arthritis	0.000295	0.000889	CcSEcCtD
Carvedilol—VCAM1—Immune System—NOD2—psoriatic arthritis	0.000294	0.00296	CbGpPWpGaD
Carvedilol—Leukopenia—Methotrexate—psoriatic arthritis	0.000294	0.000885	CcSEcCtD
Carvedilol—Urticaria—Dexamethasone—psoriatic arthritis	0.000292	0.000881	CcSEcCtD
Carvedilol—Urticaria—Betamethasone—psoriatic arthritis	0.000292	0.000881	CcSEcCtD
Carvedilol—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000292	0.00088	CcSEcCtD
Carvedilol—Dizziness—Prednisolone—psoriatic arthritis	0.000291	0.000879	CcSEcCtD
Carvedilol—Asthenia—Triamcinolone—psoriatic arthritis	0.000291	0.000877	CcSEcCtD
Carvedilol—Abdominal pain—Betamethasone—psoriatic arthritis	0.000291	0.000877	CcSEcCtD
Carvedilol—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000291	0.000877	CcSEcCtD
Carvedilol—Body temperature increased—Betamethasone—psoriatic arthritis	0.000291	0.000877	CcSEcCtD
Carvedilol—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000291	0.000877	CcSEcCtD
Carvedilol—Asthenia—Methylprednisolone—psoriatic arthritis	0.00029	0.000875	CcSEcCtD
Carvedilol—Insomnia—Prednisone—psoriatic arthritis	0.00029	0.000874	CcSEcCtD
Carvedilol—Paraesthesia—Prednisone—psoriatic arthritis	0.000288	0.000867	CcSEcCtD
Carvedilol—Pruritus—Triamcinolone—psoriatic arthritis	0.000287	0.000865	CcSEcCtD
Carvedilol—Cough—Methotrexate—psoriatic arthritis	0.000286	0.000863	CcSEcCtD
Carvedilol—Pruritus—Methylprednisolone—psoriatic arthritis	0.000286	0.000863	CcSEcCtD
Carvedilol—Convulsion—Methotrexate—psoriatic arthritis	0.000284	0.000857	CcSEcCtD
Carvedilol—Dyspepsia—Prednisone—psoriatic arthritis	0.000282	0.00085	CcSEcCtD
Carvedilol—Arthralgia—Methotrexate—psoriatic arthritis	0.000279	0.000842	CcSEcCtD
Carvedilol—Myalgia—Methotrexate—psoriatic arthritis	0.000279	0.000842	CcSEcCtD
Carvedilol—Chest pain—Methotrexate—psoriatic arthritis	0.000279	0.000842	CcSEcCtD
Carvedilol—Decreased appetite—Prednisone—psoriatic arthritis	0.000278	0.00084	CcSEcCtD
Carvedilol—Rash—Prednisolone—psoriatic arthritis	0.000278	0.000838	CcSEcCtD
Carvedilol—Dermatitis—Prednisolone—psoriatic arthritis	0.000278	0.000837	CcSEcCtD
Carvedilol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000277	0.000836	CcSEcCtD
Carvedilol—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000277	0.000835	CcSEcCtD
Carvedilol—Fatigue—Prednisone—psoriatic arthritis	0.000276	0.000833	CcSEcCtD
Carvedilol—Headache—Prednisolone—psoriatic arthritis	0.000276	0.000833	CcSEcCtD
Carvedilol—Discomfort—Methotrexate—psoriatic arthritis	0.000276	0.000832	CcSEcCtD
Carvedilol—Constipation—Prednisone—psoriatic arthritis	0.000274	0.000826	CcSEcCtD
Carvedilol—Confusional state—Methotrexate—psoriatic arthritis	0.00027	0.000814	CcSEcCtD
Carvedilol—Dizziness—Triamcinolone—psoriatic arthritis	0.000268	0.000808	CcSEcCtD
Carvedilol—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000268	0.000807	CcSEcCtD
Carvedilol—Dizziness—Methylprednisolone—psoriatic arthritis	0.000267	0.000807	CcSEcCtD
Carvedilol—Infection—Methotrexate—psoriatic arthritis	0.000266	0.000802	CcSEcCtD
Carvedilol—Feeling abnormal—Prednisone—psoriatic arthritis	0.000264	0.000796	CcSEcCtD
Carvedilol—Asthenia—Betamethasone—psoriatic arthritis	0.000264	0.000796	CcSEcCtD
Carvedilol—Asthenia—Dexamethasone—psoriatic arthritis	0.000264	0.000796	CcSEcCtD
Carvedilol—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000262	0.00079	CcSEcCtD
Carvedilol—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000262	0.00079	CcSEcCtD
Carvedilol—Nausea—Prednisolone—psoriatic arthritis	0.000262	0.00079	CcSEcCtD
Carvedilol—Pruritus—Betamethasone—psoriatic arthritis	0.00026	0.000785	CcSEcCtD
Carvedilol—Pruritus—Dexamethasone—psoriatic arthritis	0.00026	0.000785	CcSEcCtD
Carvedilol—Skin disorder—Methotrexate—psoriatic arthritis	0.00026	0.000784	CcSEcCtD
Carvedilol—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000259	0.00078	CcSEcCtD
Carvedilol—Vomiting—Triamcinolone—psoriatic arthritis	0.000258	0.000777	CcSEcCtD
Carvedilol—Vomiting—Methylprednisolone—psoriatic arthritis	0.000257	0.000776	CcSEcCtD
Carvedilol—Rash—Triamcinolone—psoriatic arthritis	0.000256	0.000771	CcSEcCtD
Carvedilol—Dermatitis—Triamcinolone—psoriatic arthritis	0.000255	0.00077	CcSEcCtD
Carvedilol—Anorexia—Methotrexate—psoriatic arthritis	0.000255	0.00077	CcSEcCtD
Carvedilol—Rash—Methylprednisolone—psoriatic arthritis	0.000255	0.000769	CcSEcCtD
Carvedilol—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000255	0.000768	CcSEcCtD
Carvedilol—Urticaria—Prednisone—psoriatic arthritis	0.000254	0.000767	CcSEcCtD
Carvedilol—Headache—Triamcinolone—psoriatic arthritis	0.000254	0.000766	CcSEcCtD
Carvedilol—Headache—Methylprednisolone—psoriatic arthritis	0.000253	0.000764	CcSEcCtD
Carvedilol—Abdominal pain—Prednisone—psoriatic arthritis	0.000253	0.000764	CcSEcCtD
Carvedilol—Body temperature increased—Prednisone—psoriatic arthritis	0.000253	0.000764	CcSEcCtD
Carvedilol—Diarrhoea—Betamethasone—psoriatic arthritis	0.000252	0.000759	CcSEcCtD
Carvedilol—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000252	0.000759	CcSEcCtD
Carvedilol—Hypotension—Methotrexate—psoriatic arthritis	0.00025	0.000754	CcSEcCtD
Carvedilol—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000244	0.000736	CcSEcCtD
Carvedilol—Dizziness—Dexamethasone—psoriatic arthritis	0.000243	0.000733	CcSEcCtD
Carvedilol—Dizziness—Betamethasone—psoriatic arthritis	0.000243	0.000733	CcSEcCtD
Carvedilol—Insomnia—Methotrexate—psoriatic arthritis	0.000242	0.00073	CcSEcCtD
Carvedilol—Nausea—Triamcinolone—psoriatic arthritis	0.000241	0.000726	CcSEcCtD
Carvedilol—Paraesthesia—Methotrexate—psoriatic arthritis	0.00024	0.000725	CcSEcCtD
Carvedilol—Nausea—Methylprednisolone—psoriatic arthritis	0.00024	0.000725	CcSEcCtD
Carvedilol—GJA1—Dexamethasone—Methylprednisolone—psoriatic arthritis	0.000239	0.0155	CbGdCrCtD
Carvedilol—GJA1—Betamethasone—Methylprednisolone—psoriatic arthritis	0.000239	0.0155	CbGdCrCtD
Carvedilol—Dyspnoea—Methotrexate—psoriatic arthritis	0.000239	0.00072	CcSEcCtD
Carvedilol—Somnolence—Methotrexate—psoriatic arthritis	0.000238	0.000718	CcSEcCtD
Carvedilol—VCAM1—Immune System—HLA-B—psoriatic arthritis	0.000236	0.00238	CbGpPWpGaD
Carvedilol—Hypersensitivity—Prednisone—psoriatic arthritis	0.000236	0.000712	CcSEcCtD
Carvedilol—GJA1—Dexamethasone—Betamethasone—psoriatic arthritis	0.000236	0.0153	CbGdCrCtD
Carvedilol—GJA1—Betamethasone—Dexamethasone—psoriatic arthritis	0.000236	0.0153	CbGdCrCtD
Carvedilol—Dyspepsia—Methotrexate—psoriatic arthritis	0.000236	0.000711	CcSEcCtD
Carvedilol—ABCB1—Allograft Rejection—HLA-B—psoriatic arthritis	0.000235	0.00237	CbGpPWpGaD
Carvedilol—Vomiting—Dexamethasone—psoriatic arthritis	0.000234	0.000705	CcSEcCtD
Carvedilol—Vomiting—Betamethasone—psoriatic arthritis	0.000234	0.000705	CcSEcCtD
Carvedilol—Decreased appetite—Methotrexate—psoriatic arthritis	0.000233	0.000702	CcSEcCtD
Carvedilol—Rash—Betamethasone—psoriatic arthritis	0.000232	0.000699	CcSEcCtD
Carvedilol—Rash—Dexamethasone—psoriatic arthritis	0.000232	0.000699	CcSEcCtD
Carvedilol—Dermatitis—Betamethasone—psoriatic arthritis	0.000232	0.000699	CcSEcCtD
Carvedilol—Dermatitis—Dexamethasone—psoriatic arthritis	0.000232	0.000699	CcSEcCtD
Carvedilol—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000231	0.000697	CcSEcCtD
Carvedilol—Fatigue—Methotrexate—psoriatic arthritis	0.000231	0.000696	CcSEcCtD
Carvedilol—Headache—Dexamethasone—psoriatic arthritis	0.00023	0.000695	CcSEcCtD
Carvedilol—Headache—Betamethasone—psoriatic arthritis	0.00023	0.000695	CcSEcCtD
Carvedilol—GJA1—Dexamethasone—Triamcinolone—psoriatic arthritis	0.00023	0.0149	CbGdCrCtD
Carvedilol—GJA1—Betamethasone—Triamcinolone—psoriatic arthritis	0.00023	0.0149	CbGdCrCtD
Carvedilol—Asthenia—Prednisone—psoriatic arthritis	0.00023	0.000693	CcSEcCtD
Carvedilol—Pain—Methotrexate—psoriatic arthritis	0.000229	0.00069	CcSEcCtD
Carvedilol—Pruritus—Prednisone—psoriatic arthritis	0.000227	0.000683	CcSEcCtD
Carvedilol—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000221	0.000665	CcSEcCtD
Carvedilol—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriatic arthritis	0.000219	0.00221	CbGpPWpGaD
Carvedilol—Diarrhoea—Prednisone—psoriatic arthritis	0.000219	0.000661	CcSEcCtD
Carvedilol—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000219	0.00066	CcSEcCtD
Carvedilol—GJA1—Betamethasone—Prednisone—psoriatic arthritis	0.000218	0.0142	CbGdCrCtD
Carvedilol—GJA1—Dexamethasone—Prednisone—psoriatic arthritis	0.000218	0.0142	CbGdCrCtD
Carvedilol—Nausea—Dexamethasone—psoriatic arthritis	0.000218	0.000659	CcSEcCtD
Carvedilol—Nausea—Betamethasone—psoriatic arthritis	0.000218	0.000659	CcSEcCtD
Carvedilol—GJA1—Dexamethasone—Prednisolone—psoriatic arthritis	0.000213	0.0138	CbGdCrCtD
Carvedilol—GJA1—Betamethasone—Prednisolone—psoriatic arthritis	0.000213	0.0138	CbGdCrCtD
Carvedilol—Urticaria—Methotrexate—psoriatic arthritis	0.000213	0.000641	CcSEcCtD
Carvedilol—Dizziness—Prednisone—psoriatic arthritis	0.000212	0.000639	CcSEcCtD
Carvedilol—Abdominal pain—Methotrexate—psoriatic arthritis	0.000212	0.000638	CcSEcCtD
Carvedilol—Body temperature increased—Methotrexate—psoriatic arthritis	0.000212	0.000638	CcSEcCtD
Carvedilol—VEGFA—Dexamethasone—Methylprednisolone—psoriatic arthritis	0.000211	0.0137	CbGdCrCtD
Carvedilol—VEGFA—Betamethasone—Methylprednisolone—psoriatic arthritis	0.000211	0.0137	CbGdCrCtD
Carvedilol—VCAM1—Immune System—CRP—psoriatic arthritis	0.000209	0.00211	CbGpPWpGaD
Carvedilol—VEGFA—Dexamethasone—Betamethasone—psoriatic arthritis	0.000208	0.0135	CbGdCrCtD
Carvedilol—VEGFA—Betamethasone—Dexamethasone—psoriatic arthritis	0.000208	0.0135	CbGdCrCtD
Carvedilol—Vomiting—Prednisone—psoriatic arthritis	0.000204	0.000614	CcSEcCtD
Carvedilol—VEGFA—Dexamethasone—Triamcinolone—psoriatic arthritis	0.000203	0.0131	CbGdCrCtD
Carvedilol—VEGFA—Betamethasone—Triamcinolone—psoriatic arthritis	0.000203	0.0131	CbGdCrCtD
Carvedilol—Rash—Prednisone—psoriatic arthritis	0.000202	0.000609	CcSEcCtD
Carvedilol—Dermatitis—Prednisone—psoriatic arthritis	0.000202	0.000608	CcSEcCtD
Carvedilol—Headache—Prednisone—psoriatic arthritis	0.000201	0.000605	CcSEcCtD
Carvedilol—VCAM1—Immune System—HLA-DRB1—psoriatic arthritis	0.0002	0.00202	CbGpPWpGaD
Carvedilol—ABCB1—Allograft Rejection—HLA-DRB1—psoriatic arthritis	0.000199	0.00201	CbGpPWpGaD
Carvedilol—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000197	0.000595	CcSEcCtD
Carvedilol—VEGFA—Betamethasone—Prednisone—psoriatic arthritis	0.000193	0.0125	CbGdCrCtD
Carvedilol—VEGFA—Dexamethasone—Prednisone—psoriatic arthritis	0.000193	0.0125	CbGdCrCtD
Carvedilol—Asthenia—Methotrexate—psoriatic arthritis	0.000192	0.000579	CcSEcCtD
Carvedilol—Nausea—Prednisone—psoriatic arthritis	0.00019	0.000574	CcSEcCtD
Carvedilol—Pruritus—Methotrexate—psoriatic arthritis	0.000189	0.000571	CcSEcCtD
Carvedilol—VEGFA—Betamethasone—Prednisolone—psoriatic arthritis	0.000188	0.0122	CbGdCrCtD
Carvedilol—VEGFA—Dexamethasone—Prednisolone—psoriatic arthritis	0.000188	0.0122	CbGdCrCtD
Carvedilol—Diarrhoea—Methotrexate—psoriatic arthritis	0.000183	0.000552	CcSEcCtD
Carvedilol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—psoriatic arthritis	0.000182	0.00183	CbGpPWpGaD
Carvedilol—CYP1A1—Aryl Hydrocarbon Receptor—TNF—psoriatic arthritis	0.000182	0.00183	CbGpPWpGaD
Carvedilol—Dizziness—Methotrexate—psoriatic arthritis	0.000177	0.000534	CcSEcCtD
Carvedilol—VEGFA—SIDS Susceptibility Pathways—TNF—psoriatic arthritis	0.000177	0.00178	CbGpPWpGaD
Carvedilol—Vomiting—Methotrexate—psoriatic arthritis	0.00017	0.000513	CcSEcCtD
Carvedilol—Rash—Methotrexate—psoriatic arthritis	0.000169	0.000509	CcSEcCtD
Carvedilol—Dermatitis—Methotrexate—psoriatic arthritis	0.000169	0.000509	CcSEcCtD
Carvedilol—Headache—Methotrexate—psoriatic arthritis	0.000168	0.000506	CcSEcCtD
Carvedilol—KCNH2—SIDS Susceptibility Pathways—TNF—psoriatic arthritis	0.00016	0.00162	CbGpPWpGaD
Carvedilol—Nausea—Methotrexate—psoriatic arthritis	0.000159	0.00048	CcSEcCtD
Carvedilol—HIF1A—Disease—NOS2—psoriatic arthritis	0.000156	0.00157	CbGpPWpGaD
Carvedilol—PTGS1—Selenium Micronutrient Network—TNF—psoriatic arthritis	0.000154	0.00155	CbGpPWpGaD
Carvedilol—VEGFA—Integrated Pancreatic Cancer Pathway—TNF—psoriatic arthritis	0.00015	0.00152	CbGpPWpGaD
Carvedilol—VEGFA—Hemostasis—NOS2—psoriatic arthritis	0.000139	0.0014	CbGpPWpGaD
Carvedilol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriatic arthritis	0.000116	0.00117	CbGpPWpGaD
Carvedilol—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriatic arthritis	0.000116	0.00117	CbGpPWpGaD
Carvedilol—ABCB1—Allograft Rejection—TNF—psoriatic arthritis	9.42e-05	0.00095	CbGpPWpGaD
Carvedilol—ADRA2B—Hemostasis—NOS2—psoriatic arthritis	8.19e-05	0.000825	CbGpPWpGaD
Carvedilol—ADRA2C—Hemostasis—NOS2—psoriatic arthritis	7.65e-05	0.000771	CbGpPWpGaD
Carvedilol—VEGFA—Developmental Biology—TNF—psoriatic arthritis	7.03e-05	0.000709	CbGpPWpGaD
Carvedilol—ADRA2A—Hemostasis—NOS2—psoriatic arthritis	6.21e-05	0.000626	CbGpPWpGaD
Carvedilol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriatic arthritis	4.65e-05	0.000469	CbGpPWpGaD
